Komori
EnBio Holdings,Inc (6092) · RiskWorsened

Foreign exchange fluctuation and exclusive distribution agreement risks associated with import sales

First written in FY2016. 4 of 8 entries say "Restated". Latest entry: FY2026.

8entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20232016: 120162017: 120172018: 020182019: 020192020: 020202021: 120212022: 020222023: 120232024: 120242025: 120252026: 22026
Same theme, other companies
Foreign exchange risk in import sales and risk that major supplier agreements will not continueA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026WorsenedAnnual report

    「③ Foreign exchange risk (likelihood: high; impact: medium; timing: short term)」

    The company explicitly assesses the likelihood of foreign exchange risk associated with U.S. dollar-denominated import transactions and electricity sales in the Middle East as “high.”
  2. 2026-05-15MitigatedEarnings presentation

    「Foreign exchange loss in the previous fiscal year: ¥27 million (@¥149.53) Foreign exchange gain in the current fiscal year: ¥100 million (@¥159.93)」

    The company reported a change from a foreign exchange loss in the previous fiscal year to a foreign exchange gain in the current fiscal year.
  3. FY2025RestatedAnnual report

    「Foreign exchange loss: ¥27.429 million」

    A foreign exchange loss was recorded during the current consolidated fiscal year in connection with foreign exchange risk associated with U.S. dollar-denominated imports and overseas transactions.
  4. FY2025-H1MaterialisedAnnual report

    「Foreign exchange loss - 113,206」

    The company recorded a foreign exchange loss of ¥113.206 million during the interim consolidated accounting period, showing the foreign exchange risk associated with imports and overseas transactions as an actual loss in earnings.
  5. FY2023RestatedAnnual report

    「The company mainly imports and sells soil contamination-related equipment, materials and remediation chemicals manufactured by North American companies. In its renewable energy business, it also sells electricity in the Middle East. Since transactions in both businesses are conducted mainly in U.S. dollars, foreign exchange fluctuations may affect the Group's financial position, operating results and other aspects of its performance.」

    The company reconfirms the foreign exchange risk associated with U.S. dollar-denominated transactions involving imports from North America and electricity sales in the Middle East.
  6. FY2021RestatedAnnual report

    「The company mainly imports and sells soil contamination-related equipment and materials manufactured by North American companies. Equipment and materials related to the newly introduced thermal desorption technology are procured from U.S. Terratherm. All such purchases are denominated in U.S. dollars, so foreign exchange fluctuations may affect the Group's financial position, operating results and other aspects of its performance.」

    The company reconfirms the foreign exchange risk associated with dollar-denominated procurement from North America and the United States.
  7. FY2017RestatedAnnual report

    「The company mainly imports and sells soil contamination-related equipment and materials manufactured by North American companies. Equipment and materials related to the newly introduced thermal desorption technology are procured from U.S. Terratherm. All such purchases are denominated in U.S. dollars, so foreign exchange fluctuations may affect the Group's financial position, operating results and other aspects of its performance.」

    The company reiterates the foreign exchange risk associated with dollar-denominated procurement from North America and the United States.
  8. FY2016First statedAnnual report

    「The soil contamination-related equipment and materials sales business accounts for approximately 20% of Group revenue. It mainly imports and sells products made by North American manufacturers and purchases them in U.S. dollars, so foreign exchange fluctuations may affect the Group's financial position, operating results and other aspects of its performance.」

    For the import sales business, which accounts for approximately 20% of revenue, the company identifies foreign exchange and the continuation of agreements with key suppliers as risks.
Moved together

"Expansion of the renewable energy business" moved the same way as this thread, in the same document, in 2 of its 8 moves.

22★12
  1. ★This thread
  2. 1Expansion of the renewable energy business2×
  3. 2Stable Securing of Liquidity and Funding Sources Required for Operations2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for EnBio Holdings,Inc yet. It last moved in the Earnings presentation of 2026-05-15: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Foreign exchange fluctuation and exclusive distribution agreement risks associated with import sales | EnBio Holdings,Inc (6092) | Komori